David D. Ossip - 08 Dec 2021 Form 4 Insider Report for Ceridian HCM Holding Inc. (DAY)

Source evidence Original filing metadata and source links for verification. 5 source fields
SEC form
4
Accepted by SEC
10 Dec 2021, 15:08:11 UTC
Prior SEC filing
11 Aug 2021
Next SEC filing
25 Feb 2022
Source filing
View source filing
Reporting owner 1 detail
Reporting owner signature
/s/ William E. McDonald, attorney-in-fact

Key filing fact

David D. Ossip filed Form 4 for Ceridian HCM Holding Inc. (DAY) on 10 Dec 2021.

Key facts

  • This page summarizes David D. Ossip's Form 4 filing for Ceridian HCM Holding Inc. (DAY).
  • 3 reported transactions and 10 derivative rows are listed below.
  • Accepted by SEC: 10 Dec 2021, 15:08.

Change

  • Previous filing in this sequence was filed on 11 Aug 2021.
  • Current net transaction value: -$41,685,000.

Research use

  • This tells you what this filing adds before you inspect full transaction and derivative tables.
  • You can trace every row back to the original SEC filing document.

Evidence

Filed on Form 4

Ownership activity is grounded in SEC Form 4 disclosures.

View source filing

Reported non-derivative transactions

Shares, units, or other non-derivative securities reported in this filing.

CDAY transaction

Common Stock

Options Exercise

Transaction value
$11,000,000
Shares
+500,000
Change %
+89%
Price
$22.00
Shares after
1,059,873
Date
08 Dec 2021
Ownership
Direct
CDAY transaction

Common Stock

Sale

Transaction value
$52,685,000
Shares
-500,000
Change %
-47%
Price
$105.37
Shares after
559,873
Date
08 Dec 2021
Ownership
Direct
Footnotes
F1
CDAY holding

Common Stock

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
229,085
Date
08 Dec 2021
Ownership
See Note
Footnotes
F2

Reported derivative securities

Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.

CDAY transaction Derivative

Option (right to buy)

Options Exercise

Transaction value
Shares
-500,000
Change %
-37%
Price
Shares after
858,697
Date
08 Dec 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
500,000
Exercise price
$22.00
Footnotes
F5, F6
CDAY holding Derivative

Exchangeable Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
8,328
Date
08 Dec 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
8,328
Exercise price
Footnotes
F3
CDAY holding Derivative

Exchangeable Shares

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,860,902
Date
08 Dec 2021
Ownership
See Note
Underlying class
Common Stock
Underlying amount
1,860,902
Exercise price
Footnotes
F3, F4
CDAY holding Derivative

Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
10,390
Date
08 Dec 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
10,390
Exercise price
$44.91
Footnotes
F7
CDAY holding Derivative

Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,750,000
Date
08 Dec 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,750,000
Exercise price
$49.93
Footnotes
F8
CDAY holding Derivative

Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
1,500,000
Date
08 Dec 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
1,500,000
Exercise price
$65.26
Footnotes
F9, F10
CDAY holding Derivative

Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
321,734
Date
08 Dec 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
321,734
Exercise price
$65.26
Footnotes
F11
CDAY holding Derivative

Option (right to buy)

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
226,931
Date
08 Dec 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
226,931
Exercise price
$80.95
Footnotes
F12
CDAY holding Derivative

Performance Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
4,942
Date
08 Dec 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
4,942
Exercise price
Footnotes
F13
CDAY holding Derivative

Performance Units

No transaction description listed

Transaction value
Shares
Change %
Price
Shares after
27,794
Date
08 Dec 2021
Ownership
Direct
Underlying class
Common Stock
Underlying amount
27,794
Exercise price
Footnotes
F14
* marks a reported price that did not pass the local price check.

Additional SEC filing notes

Filing notes and footnotes

Explanation of responses 14 footnotes

Footnote F1

Includes (i) 22,267 shares of Common Stock, (ii) 500,000 Restricted Stock Units (RSUs) granted on March 20, 2017, that are issuable at the election of the recipient; (iii) of the 3,129 RSUs granted on February 28, 2020, 1,043 shares are issuable at the election of the recipient, and 1,043 shares vest and become issuable at the election of the recipient on each of February 28, 2022 and February 28, 2023, and (iv) of the 34,477 RSUs granted on May 8, 2020, 11,492 shares are issuable at the election of the recipient, and 11,492 and 11,493 shares vest and become issuable at the election of the recipient on May 8, 2022 and May 8, 2023, respectively.

Footnote F2

Indirectly owned through OsFund Inc. The Reporting Person disclaims beneficial ownership except to the extent of the Reporting Person's pecuniary interest.

Footnote F3

Represents exchangeable shares of Ceridian AcquisitionCo ULC, a wholly owned subsidiary of the Issuer, that are exchangeable at the option of the holder for shares of common stock of the Issuer. Each exchangeable share is convertible into one share of common stock of the Issuer, subject to adjustments. The exchangeable shares are currently exercisable and have no expiration date.

Footnote F4

Indirectly owned through Osscer Inc. The Reporting Person disclaims beneficial ownership except to the extent of the Reporting Person's pecuniary interest.

Footnote F5

Consists of 1,019,022 vested and exercisable options as of April 25, 2021, and 339,675 options that vest and become exercisable on April 25, 2022.

Footnote F6

Not Applicable.

Footnote F7

Consists of 5,194 vested and exercisable options as of February 8, 2021 and 2,598 options that vest and become exercisable on each of February 8, 2022 and February 8, 2023.

Footnote F8

Consists of 875,000 vested and exercisable options as of March 20, 2021 and 437,500 options that vest and become exercisable on each of March 20, 2022 and March 20, 2023.

Footnote F9

The vesting conditions for this award are based on the Issuer's performance on the New York Stock Exchange ("NYSE") with (i) 750,000 shares available to vest when the Issuer's per share closing price on the NYSE meets or exceeds $110.94, or 1.7 times the exercise price, for ten consecutive trading days ("Performance Metric #1") and (ii) the remaining 750,000 shares are available to vest when the Issuer's per share closing price on the NYSE meets or exceeds $130.52, or 2.0 times the exercise price, for ten consecutive trading days ("Performance Metric #2", collectively with Performance Metric #1, the "Performance Metrics"). The vesting conditions of the Performance Metrics must be achieved prior to May 8, 2025, or any unvested portion of the award will terminate. Further, no portion of the award will vest and become exercisable until May 8, 2023, the third anniversary of the date of grant (the "Time-Based Metric").

Footnote F10

The shares underlying Performance Metric #1, which was achieved on October 6, 2021, will vest and become exercisable on May 8, 2023 provided that continuous employment of Mr. Ossip is maintained through that date. If Performance Metric #2 is met prior to satisfying the Time-Based Metric, the shares underlying Performance Metric #2 will vest and become exercisable on May 8, 2023 provided that continuous employment of Mr. Ossip is maintained through that date. If the Time-Based Metric is met and Performance Metric #2 has not been met on or prior to May 8, 2025, the award will be terminated.

Footnote F11

Consists of 80,433 vested and exercisable options as of May 8, 2021, 80,433 options that vest and become exercisable on May 8, 2022, and 80,434 options that vest and become exercisable on each of May 8, 2023 and May 8, 2024.

Footnote F12

These options vest and become exercisable in four annual installments beginning on March 8, 2022.

Footnote F13

Each performance stock unit represents a contingent right to receive between .25 and 1.50 shares of Common Stock based upon the degree to which one or both of the Cloud Revenue and Adjusted EBITDA Margin performance metrics under the Companys 2021 Management Incentive Plan are satisfied. The performance stock units vest upon the later of (i) the date the Compensation Committee or the Board certify that one or both of the performance metrics have been met and (ii) March 8, 2022.

Footnote F14

Each performance stock unit represents a contingent right to receive between .25 and 1.50 shares of Common Stock based upon the degree to which one or both of the Cloud Revenue and Adjusted EBITDA Margin performance metrics contained in the performance stock unit award agreement are satisfied. The performance stock units will only vest if the achievement of one or both of the performance metrics is certified by the Compensation Committee or the Board of Directors of the Company to have been met, and then any such certified amount will vest one-third on each anniversary of the date of grant.

SEC remarks

For David Ossip, pursuant to the Power of Attorney previously filed.

We use cookies and similar technologies to provide certain features, enhance the user experience and, if you allow them, measure engagement and deliver advertising. Analytics and marketing storage stay off until you grant consent. By clicking on "Agree and continue", you declare your consent to the use of the selected optional cookies. Manage preferences to update or revoke optional consent for future visits. For more information, see our Privacy Policy .